pharmaceuticals
growing markets worldwide for pharma product sales (see Panel right), the trade in that direction is expected to remain strong. Longer term, though, the same sources also anticipate a growth in pharma traffic out of many of the Asian countries. “Right now, a lot of the pharma production in China
and other Asian countries is for domestic consumption or intra-Asian markets. But in a few years’ time, outbound inter-continental shipments from Asia will grow, certainly from countries like India, Japan, Singapore, Korea and China,” Persson confirmed. Oliver Evans, chief cargo officer
for Swiss International Air Lines, described a similar picture when commenting specifically on Chinese pharma market demand
for temperature-controlled air cargo movements. “For that type of transport, China is still primarily an import market - some of our regular pharma industry customers in North America and Europe are exporting to that country,” he said. “In terms of China’s own pharma manufacturing
activities, they are beginning with some production of generic drugs. Other Asian countries, notably India, have started making a mark exporting such products on a global basis. China is taking some early steps in that direction but its production is currently still mainly for the Chinese market or intra-Asia.” Coupled with the global expansion of pharma sales and
markets is an ever more complex regulatory environment. One of the major problems for airlines and forwarders in that context is the sheer number of bodies with the authority to introduce regulations and standards relating to the management of pharma supply chains. Examples include: • The Parenteral Drug Association, a US-headquartered body which claims to be the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community worldwide, much of it related to the air freight business;
• The United States Pharmacopeia, an official public standards-setting authority for all prescription and
CHINA IS SET to become the world’s third- largest pharmaceutical market in 2011, up from number eight just four years ago, as the wider global industry undergoes a major geographical reshaping. The country will contribute an additional US$40 billion-plus in annual sales by 2013, comparable to the level of increased sales forecast for the US market over the same period. Those, at least, are two of the predictions
contained in the results of a study on the impact of emerging markets in the pharma sector published earlier this year by IMS Health, a US company providing market intelligence about the global pharmaceutical and healthcare industries. The study suggested that 17 high-growth pharmaceutical markets are now ranked as “pharmerging”. Those 17 countries will in aggregate expand by $90 billion in the period 2009-13 and contribute 48 percent of annual market growth in 2013 – up from 37 percent last year – the study predicted. “With a raft of pharmerging countries rapidly gaining market share, we’re seeing a new world order take hold within the pharmaceutical industry,” said Murray Aitken, senior vice president, Healthcare Insight, IMS. “It’s clearer than ever that the China market is in a league of its own, while an expanding group of ‘fast followers’ are building momentum and providing additional growth opportunities.” In a separate report, also published earlier this
year, IMS Health said the size of the global market for pharmaceuticals was expected to grow by nearly $300 billion over the next five years, a compound annual growth rate of 5-8 percent, to reach a value of $1.1 trillion in 2014.
AIR LOGISTICSCHINA 13
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52